MEDTRONIC SELECTSECURE LEAD MODEL 3830
Medtronic Cardiac Rhythm Disease Management · Decision date Aug 3, 2005
What did the FDA approve?
The FDA approval statement for P030036 covers the Medtronic SelectSecure Lead Model 3830. The stated scope is that the lead has applications where implantable atrial or ventricular, single-chamber or dual-chamber pacing systems are indicated, and it is intended for pacing and sensing in the atrium or ventricle.
The record identifies the device category as drug eluting permanent right ventricular or right atrial pacemaker electrodes, with product code NVN and specialty Cardiovascular. The statement does not include clinical data, safety findings, or effectiveness results, so those details are absent from this source.
FDA approval order statement
APPROVAL FOR THE SELECTSECURE LEAD MODEL 3830. THE MODEL 3830 LEAD HAS APPLICATIONS WHERE IMPLANTABLE ATRIAL OR VENTRICULAR, SINGLE-CHAMBER OR DUAL-CHAMBER PACING SYSTEMS ARE INDICATED. THE MODEL 3830 LEAD IS INTENDED FOR PACING AND SENSING IN THE ATRIUM OR VENTRICLE.
- Regulatory pathway
- Original PMA
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 3, 2005
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P030036
- Regulatory pathway
- Premarket approval application
- Product code
- NVN
- Decision code
- APPR
- Decision date
- Aug 3, 2005
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes.
- Product code
- NVN
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P030036 received
Application receipt date recorded by FDA.
P030036 · FDA decision
APPR
P030036/S162 · Related supplement
MEDTRONIC SELECTSECURE LEAD MODEL 3830
Timeline entries are records held by MedtechLedger for P030036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P030036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MEDTRONIC SELECTSECURE LEAD MODEL 3830P030036/S162 | Medtronic Cardiac Rhythm Disease Management | PMA supplement | Oct 16, 2026 | FDA |
Explore the linked device profile
Other records with product code NVN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Motorized Outer Tubing Cutter for UltiPace LeadsP960013/S135 | ABBOTT MEDICAL | PMA supplement | Oct 9, 2026 | FDA |
| ABBOTT MEDICAL | PMA approval | Jun 20, 1997 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Medtronic Cardiac Rhythm Disease Management
- Headquarters
- Not reported
- Brand website
- medtronic.com
- FDA applicant address
- 8200 Coral Sea St. N.E, Mounds View, MN, 55112
Sources and methodology
- Original FDA record: P030036
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

